Camilla Godlee

Camilla Godlee

Investigating the interactions of pathogenic bacteria with eukaryotic membranes

In the Godlee group we are studying how bacterial virulence proteins interact with eukaryotic membranes during infection and how this enables disease. In particular, we focus on Salmonella and E. coli, which together cause hundreds of millions of infections annually, with outcomes ranging from gastroenteritis to death. Through this research we are revealing new understanding into this essential element of host-pathogen interactions, as well as providing fundamental insights into cellular membrane biology.

During infection, bacterial virulence proteins have access to the organised membrane systems of the eukaryotic cell. The different ways in which virulence proteins interact with eukaryotic membranes are essential for pathogenesis. In the eukaryotic cell, a complex and diverse range of mechanisms are required to sort proteins to the appropriate membrane compartment for their functions. These include membrane recruitment, integration, and trafficking pathways. Our work explores how bacterial pathogenic proteins overcome the challenges of membrane sorting, either through hijacking eukaryotic pathways or by developing their own distinct mechanisms.

Research objectives

  • How are the interactions between bacterial virulence proteins and eukaryotic membranes mediated?

  • How do bacterial proteins hijack membrane trafficking pathways to regulate their localisation?

  • How do membrane interactions provide bacteria with pathogenic advantages?

Key publications

Godlee, C., & Holden, D. W. (2023). Transmembrane substrates of type three secretion system injectisomes. Microbiology (Reading, England), 169(1). https://doi.org/10.1099/mic.0.001292

Godlee, C., Cerny, O., Liu, M., Blundell, S., Gallagher, A. E., Shahin, M., & Holden, D. W. (2022). The Salmonella transmembrane effector SteD hijacks AP1-mediated vesicular trafficking for delivery to antigen-loading MHCII compartments. PLoS Pathogens, 18(5), e1010252. https://doi.org/10.1371/journal.ppat.1010252

Cerny, O., Godlee, C., Tocci, R., Cross, N. E., Shi, H., Williamson, J. C., Alix, E., Lehner, P. J., & Holden, D. W. (2021). CD97 stabilises the immunological synapse between dendritic cells and T cells and is targeted for degradation by the Salmonella effector SteD. PLoS Pathogens, 17(7), e1009771. https://doi.org/10.1371/journal.ppat.1009771

Alix, E., Godlee, C., Cerny, O., Blundell, S., Tocci, R., Matthews, S., Liu, M., Pruneda, J. N., Swatek, K. N., Komander, D., Sleap, T., & Holden, D. W. (2020). The Tumour Suppressor TMEM127 Is a Nedd4-Family E3 Ligase Adaptor Required by Salmonella SteD to Ubiquitinate and Degrade MHC Class II Molecules. Cell Host & Microbe, 28(1), 54-68.e7. https://doi.org/10.1016/j.chom.2020.04.024

Godlee, C., Cerny, O., Durkin, C. H., & Holden, D. W. (2019). SrcA is a chaperone for the Salmonella SPI-2 type three secretion system effector SteD. Microbiology (Reading, England), 165(1), 15–25. https://doi.org/10.1099/mic.0.000732

Brach, T., Godlee, C., Moeller-Hansen, I., Boeke, D., & Kaksonen, M. (2014). The initiation of clathrin-mediated endocytosis is mechanistically highly flexible. Current Biology : CB, 24(5), 548–554. https://doi.org/10.1016/j.cub.2014.01.048

Godlee, C., & Kaksonen, M. (2013). From uncertain beginnings: Initiation mechanisms of clathrin-mediated endocytosis. The Journal of Cell Biology, 203(5), 717–725. https://doi.org/10.1083/jcb.201307100